Carotuximab Completed Phase 2 Trials for Glioblastoma Multiforme (GBM) / High Grade Glioma: Glioblastoma (GBM) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01564914 | A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma |